...
首页> 外文期刊>brain pathology >Desmoplastic Infantile Ganglioglioma and Desmoplastic Cerebral Astrocytoma of Infancy
【24h】

Desmoplastic Infantile Ganglioglioma and Desmoplastic Cerebral Astrocytoma of Infancy

机译:Desmoplastic Infantile Ganglioglioma and Desmoplastic Cerebral Astrocytoma of Infancy

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy are rare neoplasms arising in the cerebral hemispheres within the first two years of life which are defined by a combination of distinctive clinicopathologic features. The tumours are massive, partially cystic and invariably occur in a supratentorial location. Involvement of multiple lobes is common with a predilection for frontoparietal areas. In one series of 22 desmoplastic infantile gangliogliomas, all patients presented between 2 and 24 months of age (mean = 6 months; median = 4 months) with a male to female ratio of 1.4: 1. In the nine reported cases of the desmoplastic cerebral astrocytoma of infancy, all patients presented between 1.5 and 14 months of age (mean = 6.8 months; median = 6 months) with a male to female ratio 0.8: 1. The hallmark feature of both neoplasms is an abundant and often dense desmoplasia, imparting a characteristic firmness to the neoplasms. In the desmoplastic infantile gangliogliomas, astroglial and neuronal tumour cells in addition to variable numbers of more primitive, mitotic cells comprise the neoplastic neuroepithelial populations. In contrast, the neuroepithelial component of the desmoplastic infantile astrocytomas is restricted to neoplastic astrocytes. Despite the large size, cellular pleomorphism and cellular atypia, prognosis following successful surgical resection in both types of tumours is quite favorable. The longest followup data is available for the desmoplastic infantile gangliogliomas. With the median interval of 8.7 years (range 1 to 14.5 years) following surgery for 14 patients in this series, there were no deaths due to tumour or any evidence of tumour recurrence. Likewise for the astrocytomas, with a median followup of 1.5 years (≥5.5 years), there was no evidence of tumour recurrenc

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号